Client is a biopharmaceutical company that develops medicines in areas of unmet need.
Medicare Part D reform. Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements proposed rule (85 FR 37286). Remdesivir education and awareness campaign. Reforms related to the pharmaceutical supply chain.
MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
JOHN MCMANUS ALANNA TEMME (LD, Rep. Jon Porter) JOHN MCMANUS ALANNA TEMME
LD, Rep. Jon Porter